S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Deep Track Capital/Q4 2025

Deep Track Capital

Periodo: Q4 2025 · Depositato: 2026-02-13
Vedi su SEC EDGAR
AUM
$5.61B
Valore totale del portafoglio
Posizioni
55
Titoli dichiarati
Prima Posizione
XBI
21.7% $1.22B
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2026-02-13) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
XBIPUTSPDR SERIES TRUST$1.22B21.74%$121.81$160.46+31.7%
21.7%
IMVTIMMUNOVANT INC$293.0M5.22%$25.42$38.79+52.6%
5.2%
GHGUARDANT HEALTH INC$286.0M5.10%$102.14$167.98+64.5%
5.1%
GPCRSTRUCTURE THERAPEUTICS INC$286.0M5.10%$69.55$53.45-23.1%
5.1%
TARSTARSUS PHARMACEUTICALS INC$246.0M4.39%$81.88$65.44-20.1%
4.4%
DVAXDYNAVAX TECHNOLOGIES CORP$241.9M4.31%
4.3%
CYTKCYTOKINETICS INC$212.0M3.78%$63.54$86.49+36.1%
3.8%
AXSMAXSOME THERAPEUTICS INC$210.0M3.74%$182.64$244.31+33.8%
3.7%
APLSAPELLIS PHARMACEUTICALS INC$194.7M3.47%$25.12
3.5%
PCVXVAXCYTE INC$184.6M3.29%$46.14$58.39+26.6%
3.3%
MAZEMAZE THERAPEUTICS INC$175.9M3.14%$41.43$31.26-24.6%
3.1%
VERAVERA THERAPEUTICS INC$142.9M2.55%$50.64$41.20-18.6%
2.5%
BMRNBIOMARIN PHARMACEUTICAL INC$136.7M2.44%$59.43$58.99-0.7%
2.4%
IONSIONIS PHARMACEUTICALS INC$134.5M2.40%$79.11$81.80+3.4%
2.4%
NRIXNURIX THERAPEUTICS INC$133.5M2.38%$18.97$23.97+26.4%
2.4%
MBXMBX BIOSCIENCES INC$102.5M1.83%$31.54$57.80+83.3%
1.8%
OCULOCULAR THERAPEUTIX INC$98.0M1.75%$12.14$9.64-20.6%
1.8%
GRALGRAIL INC$87.5M1.56%$85.59$69.11-19.3%
1.6%
VRDNVIRIDIAN THERAPEUTICS INC$78.6M1.40%$31.12$19.40-37.7%
1.4%
LBRXLB PHARMACEUTICALS INC$74.6M1.33%$22.26$33.43+50.2%
1.3%
IMCRIMMUNOCORE HLDGS PLC$69.6M1.24%$34.71$32.50-6.4%
1.2%
ORKAORUKA THERAPEUTICS INC$65.5M1.17%$30.31$85.21+181.1%
1.2%
BBIOBRIDGEBIO PHARMA INC$62.0M1.10%$76.49$77.19+0.9%
1.1%
CRMDCORMEDIX INC$61.3M1.09%$11.63$8.75-24.8%
1.1%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$60.8M1.08%$13.18$18.95+43.8%
1.1%
ALKSALKERMES PLC$56.0M1.00%$27.98$54.58+95.1%
1.0%
DYNDYNE THERAPEUTICS INC$51.8M0.92%$19.56$23.07+17.9%
0.9%
CLDXCELLDEX THERAPEUTICS INC NEW$51.6M0.92%$27.16$38.37+41.3%
0.9%
CMPSCOMPASS PATHWAYS PLC$50.6M0.90%$6.90$13.62+97.4%
0.9%
CNTACENTESSA PHARMACEUTICALS PLC$50.0M0.89%$25.01$40.50+61.9%
0.9%

Attività Trimestre su Trimestre

Q4 2025 vs. Q3 2025

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
XBIPUTSPDR SERIES TRUST$1.22B+31.7%
VERAVERA THERAPEUTICS INC$142.9M-18.6%
GRALGRAIL INC$87.5M-19.3%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$60.8M+43.8%
ALKSALKERMES PLC$56.0M+95.1%
CNTACENTESSA PHARMACEUTICALS PLC$50.0M+61.9%
SLNOSOLENO THERAPEUTICS INC$46.3M
VSTMVERASTEM INC$44.3M

Posizioni Chiuse (8)

TickerEmittenteNozionale
AKROAKERO THERAPEUTICS INC$190.0M
ETNB89BIO INC$137.5M
PTGXPROTAGONIST THERAPEUTICS INC$114.0M
EXASEXACT SCIENCES CORP$54.7M
OLMAOLEMA PHARMACEUTICALS INC$34.0M
CDTXCIDARA THERAPEUTICS INC$28.7M
QUREUNIQURE NV$28.2M
JBIOJADE BIOSCIENCES INC$19.7M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
BMRNBIOMARIN PHARMACEUTICAL INC$135.3M+9153.3%-0.7%
CRMDCORMEDIX INC$55.5M+954.8%-24.8%
XFORX4 PHARMACEUTICALS INC$16.2M+346.7%
ENGNENGENE HOLDINGS INC$24.2M+95.5%
HELPCYBIN INC$9.3M+85.4%
TNGXTANGO THERAPEUTICS INC$9.5M+68.7%
PCVXVAXCYTE INC$76.5M+33.3%+26.6%
DYNDYNE THERAPEUTICS INC$26.5M+32.5%+17.9%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
TERNTERNS PHARMACEUTICALS INC$-25.2M-89.7%
RAPTRAPT THERAPEUTICS INC$-15.6M-85.3%
XENEXENON PHARMACEUTICALS INC$-31.8M-69.5%
IONSIONIS PHARMACEUTICALS INC$-114.6M-55.4%+3.4%
VRDNVIRIDIAN THERAPEUTICS INC$-37.5M-53.1%-37.7%
GHGUARDANT HEALTH INC$26.4M-32.6%+64.5%
BBIOBRIDGEBIO PHARMA INC$-0.4M-32.5%+0.9%
OCULOCULAR THERAPEUTIX INC$-41.5M-32.4%-20.6%
Torna agli Hedge Fund